170 related articles for article (PubMed ID: 18705641)
1. Comparative evaluation of genetic assays to identify oral pre-cancerous fields.
Bremmer JF; Braakhuis BJ; Brink A; Broeckaert MA; Beliën JA; Meijer GA; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
J Oral Pathol Med; 2008 Nov; 37(10):599-606. PubMed ID: 18705641
[TBL] [Abstract][Full Text] [Related]
2. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y
J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544
[TBL] [Abstract][Full Text] [Related]
3. Screening for oral precancer with noninvasive genetic cytology.
Bremmer JF; Graveland AP; Brink A; Braakhuis BJ; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
Cancer Prev Res (Phila); 2009 Feb; 2(2):128-33. PubMed ID: 19174582
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
[TBL] [Abstract][Full Text] [Related]
5. Loss of p53 gene as a biomarker of high risk oral leukoplakias.
Saranath D; Tandle AT; Deo MG; Mehta AR; Sanghvi V
Indian J Biochem Biophys; 1997 Jun; 34(3):266-73. PubMed ID: 9425746
[TBL] [Abstract][Full Text] [Related]
6. A genetic progression model of oral cancer: current evidence and clinical implications.
Braakhuis BJ; Leemans CR; Brakenhoff RH
J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients.
Poh CF; Zhang L; Anderson DW; Durham JS; Williams PM; Priddy RW; Berean KW; Ng S; Tseng OL; MacAulay C; Rosin MP
Clin Cancer Res; 2006 Nov; 12(22):6716-22. PubMed ID: 17121891
[TBL] [Abstract][Full Text] [Related]
9. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
Scheifele C; Schlechte H; Bethke G; Reichart PA
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment of oral cancer in patients with pre-cancerous states of the oral cavity using micronucleus test and challenge assay.
Saran R; Tiwari RK; Reddy PP; Ahuja YR
Oral Oncol; 2008 Apr; 44(4):354-60. PubMed ID: 17936677
[TBL] [Abstract][Full Text] [Related]
11. Genomic instability and tumor-specific DNA alterations in oral leukoplakias.
Tanić N; Tanić N; Milasin J; Vukadinović M; Dimitrijević B
Eur J Oral Sci; 2009 Jun; 117(3):231-7. PubMed ID: 19583749
[TBL] [Abstract][Full Text] [Related]
12. Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer.
Acha A; Ruesga MT; Rodríguez MJ; Martínez de Pancorbo MA; Aguirre JM
Med Oral Patol Oral Cir Bucal; 2005; 10(2):95-102. PubMed ID: 15735540
[TBL] [Abstract][Full Text] [Related]
13. Field effect in oral precancer as assessed by DNA flow cytometry and array-CGH.
Pentenero M; Donadini A; Di Nallo E; Maffei M; Marino R; Familiari U; Castagnola P; Gandolfo S; Giaretti W
J Oral Pathol Med; 2012 Feb; 41(2):119-23. PubMed ID: 21950471
[TBL] [Abstract][Full Text] [Related]
14. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
15. A noninvasive genetic screening test to detect oral preneoplastic lesions.
Bremmer JF; Braakhuis BJ; Ruijter-Schippers HJ; Brink A; Duarte HM; Kuik DJ; Bloemena E; Leemans CR; van der Waal I; Brakenhoff RH
Lab Invest; 2005 Dec; 85(12):1481-8. PubMed ID: 16127456
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of oral precancerous lesions].
Sudbø J; Warloe T; Aamdal S; Reith A; Bryne M
Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3066-71. PubMed ID: 11757442
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of premalignant oral lesions.
Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
[TBL] [Abstract][Full Text] [Related]
18. Lack of molecular markers to predict malignant potential of oral precancer.
Warnakulasuriya S
J Pathol; 2000 Mar; 190(4):407-9. PubMed ID: 10699986
[TBL] [Abstract][Full Text] [Related]
19. Leukoplakia: molecular understanding of pre-malignant lesions and implications for clinical management.
Mao L
Mol Med Today; 1997 Oct; 3(10):442-8. PubMed ID: 9358471
[TBL] [Abstract][Full Text] [Related]
20. MLPA as a screening method of aneuploidy and unbalanced chromosomal rearrangements in spontaneous miscarriages.
Diego-Alvarez D; Rodriguez de Alba M; Cardero-Merlo R; Diaz-Recasens J; Ayuso C; Ramos C; Lorda-Sanchez I
Prenat Diagn; 2007 Aug; 27(8):765-71. PubMed ID: 17546698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
